SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2255so a sold my small mygn position pending the outcome of this hearing. not sure abob zagorin-9/30/2009
2254That's quite a line up to contend against in the court of public opinion at tom pope-9/30/2009
2253Stakes rise in gene-patenting lawsuit Research » Hearing today pits AMA, sim1-9/30/2009
2252Tomorrow a federal district court judge is expected to hear MYGN's motion toidos-9/29/2009
2251AH last nite.. "...Stephens believes Myriad is well positioned in the specbob zagorin-9/29/2009
2250Some Portuguese carry mutation that causes breast cancer By: Lurdes Csim1-9/28/2009
2249[Myriad Pharmaceuticals] - New HIV Drug Shows Promising Results sim1-9/19/2009
2248Myriad Pharmaceuticals Announces Two Abstracts Selected for Presentation At 2009sim1-9/12/2009
2247Myriad Genetics, Inc F4Q09 (Qtr End 06/30/09) Earnings Call Transcript Myriad sim1-8/26/2009
2246Myriad Genetics beats by $0.15, reports revs in-line; co is comfortable with curA.J. Mullen-8/25/2009
2245BARRON'S TAKE 7/1/09 Myriad Problems for Myriad Genetics By TERESA RIVAmopgcw17/5/2009
2244GHDX's OncotypeDX assay is a gene expression profile. It is performed using idos-7/3/2009
2243citi: Myriad Genetics Inc (MYGN) Disappointing Preannouncement; Reducing PT to $mopgcw-7/3/2009
2242<i>BRCA testing</i> I was thinking the GHDX was doing the same sortSteve Lokness-7/3/2009
2241BRCA testing, which accounts for a very large part of MYGN's sales is obviouidos-7/3/2009
2240ecrire; <i>They have an indispensable product for which world wide demandSteve Lokness-7/2/2009
2239Very difficult to hold onto this one, but still believe patience will be rewardeecrire-7/2/2009
22382nd consecutive quarter of minimal sequential revenue growth reuters.comidos-7/1/2009
2237New drugs could transform cancer treatment PARP inhibitors appear to destroy disim1-6/26/2009
2236Ashley..... >> It does support your contention that the pharma pipeline hscaram(o)uche-6/23/2009
2235Go check out FACT for another similar reaction, and it can continue for a long tRobohogs-6/23/2009
2234I'm surprised. The pharma was valued only at around 5% of the parent on lauA.J. Mullen-6/17/2009
2233Why not, as I presume that Hobden went to the new company?? ;-( aside..... scaram(o)uche-6/15/2009
2232looks like the shorting of Myriad Pharma is starting right out the gate today, dmopgcw-6/15/2009
2231Myriad Genetics Announces Effectiveness of Myriad Pharmaceuticals Registration Ssim1-6/11/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News